Hospitals

Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)

CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation...

Life Science Software Market Size, Share, Trends, Key Players, Revenue Outlook and Market to Gain USD 40.76 Billion by 2029

DURBAN, South Africa, July 14, 2022 /PRNewswire/ -- "Global Life Science Software Market" the new research report adds in Data Bridge...

MDbio Start Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Anxiety and Pain; Expected Retail From 2023

Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade...

error: Content is protected !!